NEW YORK, NY / ACCESSWIRE / August 18, 2017 / U.S. markets tumbled Thursday on news of a terrorist attack in London and growing concerns that the recent controversies surrounding President Trump would impact his economic agenda. There had been fears in early trading Thursday that Gary Cohn, the director of the president's National Economic Council, would resign following President Trump's remarks on the violent protests in Charlottesville, VA. The Dow Jones Industrial Average plunged 1.24 percent, its largest daily decline in three-months, to close at 21,750.73, while the S&P 500 Index fell 1.54 to close at 2,430.01. The NASDAQ Composite Index dropped 1.54 percent to close at 6,221.91.

"In Europe, we had weakness out of the gate and then we had worries about the Cohn news," said Mark Kepner, managing director of sales and trading at Themis Trading, in an interview. "With the light volume, Barcelona is not something that the market is going to handle well."

RDI Initiates Coverage on:

Corcept Therapeutics Inc.
https://ub.rdinvesting.com/news/?ticker=CORT

Opko Health Inc.
https://ub.rdinvesting.com/news/?ticker=OPK

Corcept Therapeutics Inc.'s stock moved 5.01% lower Thursday, to close the day at $14.60. The stock recorded a trading volume of 1,475,739 shares, which was above its three months average volume of 1,061,800 shares. In the last year Corcept Therapeutics Inc.'s shares have traded in a range of 5.24 - 15.58. The share price has gained 178.63% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $12.91 is greater than its 200-day moving average of $10.84. Shares of the company are trading at a Price to Earnings ratio of 72.64. Shares of Corcept Therapeutics have gained approximately 101.1 percent year-to-date.

Access RDI's Corcept Therapeutics Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=CORT

On Thursday, shares of Opko Health Inc. recorded a trading volume of 5,130,859 shares, which was above the three months average volume of 4,164,840 shares. The stock ended the day 2.97% lower at 5.88. The stock is currently trading 51.60% below its 52 week high with a 52 week trading range of 5.85 - 12.15.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $6.28 is below its 200-day moving average of $7.21. Shares of Opko Health have fallen approximately 36.77 percent year-to-date.

Access RDI's Opko Health Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=OPK

Our Actionable Research on Corcept Therapeutics Inc. (NASDAQ:CORT) and Opko Health Inc. (NASDAQ:OPK) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com